The hippocampus is critical for memory and spatial navigation, and is central to the pathophysiology of temporal lobe epilepsy – the most common drug-resista…
Medical Cannabis and Epilepsy: The Evidence.
Epilepsy is a serious neurological condition that can affect individuals of all ages. Treatment is far from perfect, and roughly 30% of patients can experien…
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this randomized controlled trial, CBD at both low (30 mg) and high (700 mg) single doses failed to directly reduce cortical excitability in healthy adults, suggesting its anti-seizure effects...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In a controlled crossover trial of healthy males, CBD at both low and high doses did not directly reduce cortical excitability compared to placebo, suggesting its anti-seizure benefits may depend...
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this controlled trial of healthy adults, neither a low nor a high single dose of CBD directly altered cortical excitability compared to placebo, suggesting CBD may not have meaningful...
`Cannabidiol & Cortical Excitability: Clinical Trial Findings`
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial in healthy adults, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability compared to placebo. This...
Cannabinoids in Children: Medical Evidence Reviewed
Clinical Takeaway Cannabinoids have been studied across a wide range of pediatric medical conditions, with evidence drawn from interventional trials, observational data, and surveys. The current body of research reflects both potential...
`Cannabidiol & Cortical Excitability: Clinical Trial Evidence`
Clinical Takeaway In a controlled crossover trial of healthy males, CBD at both low and high single doses failed to directly reduce cortical excitability compared to placebo, suggesting its anti-seizure effects may...
`Cannabinoid Clinical Trials: CBD and Cortical Excitability`
Clinical Takeaway In a controlled crossover trial of healthy adults, CBD at both low (30 mg) and high (700 mg) single doses showed no direct effect on cortical excitability compared to placebo....
Endocannabinoid System Research: CBD & Cortical Excitability
Clinical Takeaway In a controlled crossover trial in healthy adults, CBD at both low and high doses showed no direct effect on cortical excitability compared to placebo, suggesting its anti-seizure benefit may...